Device Trial Radar · NCT01957904
ArterX Safety and Efficacy Study for Cardiac Indications
Last checked: Nov 19, 2026Latest source record: Nov 17, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Jun 2013
Primary completion
Sep 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- Tenaxis Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 8, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to confirm the acute safety and performance of the ArterX® Surgical Sealant as a hemostatic agent. The study will collect data in support of publications and future product labeling revisions, to provide additional clinical information on use and further details regarding product safety.
Conditions
- Vascular Disease
Interventions
ArterX Surgical SealantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects with immediate sealing of suture/staple lineTime frame: during surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Krankenhaus Der Barmherzigen Bruder
Trier, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.